Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “statin”

170 pharma patents match "statin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 170
Index total 30,257
Page 5 / 8

Quick answer

This filtered view shows 170 pharmaceutical patents matching "statin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

170 results for “statin” · 30,257 patents in full index Clear search

  1. US 7812117

    Vasostatin as marrow protectant

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  2. US 7807640

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted
  3. US 7777034

    Crystalline ammonium salts of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  4. US 7741482

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  5. US 7709643

    Synthesis of sodium narcistatin and related compounds

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  6. US 7705188

    Structural modification of resveratrol: sodium resverastatin phosphate

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  7. US 7692008

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  8. US 7692009

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  9. US 7692010

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  10. US 7687642

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  11. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  12. US 7612203

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  13. US 7582759

    Diastereomeric purification of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  14. US 7557096

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted
  15. US 7547686

    Combretastatin A-3 prodrug

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  16. US 7541346

    Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 2, 2009 · Expires May 28, 2029

    granted
  17. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  18. US 7531514

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted May 12, 2009 · Expires May 7, 2029

    granted
  19. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  20. US 7488480

    Use of passive myostatin immunization in egg laying vertebrates

    Regents of the University of Minnesota · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  21. US 7488750

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  22. US 7468444

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted
  23. US 7462609

    Narcistatin prodrugs

    THE ARIZONA BOARD OF REGENTS · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted
  24. US 7456297

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted